Skip to main content

Resources tagged with “viabahn”

One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions

Sep 20, 2016

FDA Approves GORE® VIABAHN® Endoprosthesis for Revision of the Arteriovenous Access

Flexibility and Durability to Aid Hemodialysis Patients

Dec 11, 2013

Prospective, randomized comparison of VIABAHN Stent-Graft versus SilverHawk atherectomy for de novo femoropopliteal occlusive disease.

Kazemi S, Bangash A, Djelmami-Hani M, et al. Prospective, randomized comparison of VIABAHN Stent-Graft versus SilverHawk atherectomy for de novo femoropopliteal occlusive disease. Abstract presented at the 18th Annual Scientific Symposium of the Transcatheter Cardiovascular Therapeutics (TCT); October 22-27, 2006; Washington, DC. American Journal of Cardiology 2006; 98(8)Supplement S1:10M. TCT-20..

PDF, 340.56 KB

Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis

GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions

Feb 20, 2014

Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease

Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies

Feb 4, 2015